Your browser doesn't support javascript.
loading
In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants.
Hoornaert, Chloé J; Luyckx, Evi; Reekmans, Kristien; Dhainaut, Maxime; Guglielmetti, Caroline; Le Blon, Debbie; Dooley, Dearbhaile; Fransen, Erik; Daans, Jasmijn; Verbeeck, Louca; Quarta, Alessandra; De Vocht, Nathalie; Lemmens, Evi; Goossens, Herman; Van der Linden, Annemie; Roobrouck, Valerie D; Verfaillie, Catherine; Hendrix, Sven; Moser, Muriel; Berneman, Zwi N; Ponsaerts, Peter.
Affiliation
  • Hoornaert CJ; Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium.
  • Luyckx E; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Reekmans K; Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium.
  • Dhainaut M; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Guglielmetti C; Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium.
  • Le Blon D; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Dooley D; Laboratory of Immunobiology, Department of Molecular Biology, Université Libre de Bruxelles, Gosselies, Belgium.
  • Fransen E; Bio-Imaging Laboratory, University of Antwerp, Antwerp, Belgium.
  • Daans J; Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium.
  • Verbeeck L; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Quarta A; Department of Morphology, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • De Vocht N; StatUa Centre for Statistics, University of Antwerp, Antwerp, Belgium.
  • Lemmens E; Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium.
  • Goossens H; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Van der Linden A; Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium.
  • Roobrouck VD; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Verfaillie C; Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium.
  • Hendrix S; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Moser M; Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium.
  • Berneman ZN; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Ponsaerts P; Department of Morphology, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Stem Cells ; 34(7): 1971-84, 2016 07.
Article de En | MEDLINE | ID: mdl-26992046
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Activation des lymphocytes / Lymphocytes T / Interleukine-13 / Transplantation de cellules souches mésenchymateuses / Cellules souches mésenchymateuses / Survie du greffon / Isoantigènes / Macrophages Limites: Animals Langue: En Journal: Stem Cells Année: 2016 Type de document: Article Pays d'affiliation: Belgique Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Activation des lymphocytes / Lymphocytes T / Interleukine-13 / Transplantation de cellules souches mésenchymateuses / Cellules souches mésenchymateuses / Survie du greffon / Isoantigènes / Macrophages Limites: Animals Langue: En Journal: Stem Cells Année: 2016 Type de document: Article Pays d'affiliation: Belgique Pays de publication: Royaume-Uni